Linked Life Data

15625332

Source:http://linkedlifedata.com/resource/pubmed/id/15625332

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
27
pubmed:dateCreated
2004-12-30
pubmed:abstractText
Pegaptanib, an anti-vascular endothelial growth factor therapy, was evaluated in the treatment of neovascular age-related macular degeneration.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2004 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
30
pubmed:volume
351
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2805-16
pubmed:dateRevised
2007-5-2
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Pegaptanib for neovascular age-related macular degeneration.
pubmed:affiliation
Retina Service, Massachusetts Eye and Ear Infirmary and Harvard Medical School, 243 Charles St., Boston, MA 02114, USA. evangelos_gragoudas@meei.harvard.edu
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study